← All organizations

Mati Therapeutics Inc.

For profitWebsite ↗

Also known as: Mati Therapeutics | Mati Therapeutics Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Sep 8, 2021

Timeline

2010s

Jan 1, 2012
Mati Therapeutics Inc.— Founded

Drugs by trial phase (5 distinct, 14 trials)

Phase 2 (4 own, 0 via acquisition)

Other trials (1 own, 0 via acquisition)

travoprost

Indications

Studied for

Recent trials (15)

NCT04962009Lead sponsorN/ASep 8, 2021
NCT03496467Lead sponsorPhase 2Mar 5, 2018
NCT03496467Study directorPhase 2Mar 5, 2018
NCT02014142Lead sponsorPhase 2Dec 1, 2013
NCT01481051Lead sponsorPhase 2Nov 1, 2011
NCT01481077Lead sponsorPhase 2Nov 1, 2011
NCT01287338Lead sponsorPhase 2Oct 1, 2010
NCT01229982Lead sponsorPhase 2Oct 1, 2010
NCT01037036Lead sponsorPhase 2Dec 1, 2009
NCT00967811Lead sponsorPhase 2Aug 1, 2009
NCT00855517Lead sponsorPhase 2Mar 1, 2009
NCT00821002Lead sponsorPhase 2Jan 1, 2009
NCT00845299Lead sponsorPhase 2Jan 1, 2009
NCT00820300Lead sponsorPhase 2Jan 1, 2009
NCT00650702Lead sponsorPhase 2Mar 1, 2008

Details

Founded: Austin, TX, US Jan 1, 2012
Last known activity: Sep 8, 2021